Glenmark gets tentative USFDA nod to sell Rufinamide

Glenmark Pharmaceuticals today said it has been granted tentative approval by the US health regulator to sell Rufinamide.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news